Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
暂无分享,去创建一个
T. Phillips | C. Murga-Zamalloa | A. Hristov | N. Brown | R. Wilcox | W. Hanel | Tianjiao Wang | K. Inamdar | Pradeep J Poonnen | S. Devata | J. Gomez-Gelvez | N. Bailey | Avery Polk | Pinki Chowdhury